Acacia Pharma has a portfolio of approved and near-market products targeting large and growing markets with significant unmet medical needs.
Postoperative nausea & vomiting (PONV)
PONV is a common complication of surgery, occurring in approximately 30% of surgical patients and up to 80% of high-risk patients.
For use during invasive medical procedures, such as colonoscopy and bronchoscopy.
Chemotherapy induced nausea & vomiting (CINV)
CINV is one of the most common and feared side effects of cancer chemotherapy.
Acacia Pharma Announces Early Repayment of Loan Facility from Hercules Technology Growth Capital
Acacia Pharma Becomes New Industry Supporter of the American Society of Anesthesiologists
Publication of Annual Report and Financial Statements for the Year ended 31 December 2020
View all news